Cargando…
Diabetes mellitus: Exploring the challenges in the drug development process
Diabetes mellitus has reached epidemic proportions and continues to be a major burden on society globally. The International Diabetes Federation (IDF) estimated the global burden of diabetes to be 366 million in 2011 and predicted that by 2030 this will have risen to 552 million. In spite of newer a...
Autores principales: | Vaz, Julius A., Patnaik, Ashis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487225/ https://www.ncbi.nlm.nih.gov/pubmed/23125962 http://dx.doi.org/10.4103/2229-3485.100660 |
Ejemplares similares
-
Biperiden Challenge Model in Healthy Elderly as Proof‐of‐Pharmacology Tool: A Randomized, Placebo‐Controlled Trial
por: Bakker, Charlotte, et al.
Publicado: (2021) -
Epitope Mapping: The First Step in Developing Epitope-Based Vaccines
por: Gershoni, Jonathan M., et al.
Publicado: (2012) -
The Cardiovascular Effects of a Meal: J‐T(peak) and T(peak)‐T(end) Assessment and Further Insights Into the Physiological Effects
por: Täubel, Jörg, et al.
Publicado: (2019) -
Personalized medicine: Striding from genes to medicines
por: Nair, Sunita R.
Publicado: (2010) -
Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: t(last) (Common)
por: Fisher, Dennis, et al.
Publicado: (2015)